OK Biotech Co., Ltd. (TPE:4155)
Taiwan · Delayed Price · Currency is TWD 13.35
+0.05 (0.38%)
At close: Mar 27, 2026
OK Biotech Revenue
In the year 2025, OK Biotech had annual revenue of 1.56B TWD, down -6.81%. OK Biotech had revenue of 337.58M in the quarter ending December 31, 2025, a decrease of -19.76%.
Revenue
1.56B
Revenue Growth
-6.81%
P/S Ratio
1.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.56B | -113.74M | -6.81% |
| Dec 31, 2024 | 1.67B | 478.05M | 40.11% |
| Dec 31, 2023 | 1.19B | -291.54M | -19.65% |
| Dec 31, 2022 | 1.48B | 220.15M | 17.43% |
| Dec 31, 2021 | 1.26B | -221.04M | -14.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.40B |
| Dynamic Medical Technologies | 1.39B |
| AViTA | 936.39M |
| Bioptik Technology Incorporation | 837.19M |
| A Plus Biotechnology | 835.89M |
| Diamond Biotechnology | 698.11M |